Abingdon Health (LON:ABDX) Stock Price Down 2.6% – Here’s Why

Abingdon Health Plc (LON:ABDX – Get Free Report) traded down 2.6% during mid-day trading on Thursday . The stock traded as low as GBX 9.50 and last traded at GBX 9.50. 5,535 shares traded hands during trading, a decline of 98% from the average daily volume of 281,822 shares. The stock had previously closed at GBX 9.75.

Abingdon Health Trading Down 2.6%

The company has a market cap of £23.85 million, a P/E ratio of -11.73 and a beta of 0.16. The business has a fifty day simple moving average of GBX 11.29 and a 200 day simple moving average of GBX 8.79. The company has a debt-to-equity ratio of 15.05, a quick ratio of 1.96 and a current ratio of 1.91.

Abingdon Health Company Profile

(Get Free Report)

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.

Further Reading

• Five stocks we like better than Abingdon Health
• Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
• Revving Up Returns: Big Banks Race Through the Rate Plateau
• Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
• Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test